Dermata receives Australian patent acceptance for acne treatment
Go back to Dermata receives Australian patent acceptance for acne treatment| (NASDAQ: DRMA) | Delayed: 1.17 +0.05 (4.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.12 | 52 Week High | $ | |||
| Open | $1.15 | 52 Week Low | $ | |||
| Day High | $1.25 | P/E | N/A | |||
| Day Low | $1.12 | EPS | $ | |||
| Volume | 78,096 | |||||
| (NASDAQ: DRMAW) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $ | |||
| Open | $0.00 | 52 Week Low | $ | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $ | |||
| Volume | 587,885 | |||||
